Lipidor Ab (LIPI) - Total Liabilities

Latest as of December 2024: Skr3.86 Million SEK ≈ $415.29K USD

Based on the latest financial reports, Lipidor Ab (LIPI) has total liabilities worth Skr3.86 Million SEK (≈ $415.29K USD) as of December 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Lipidor Ab net asset momentum to track the company's year-over-year net asset growth rate.

Lipidor Ab - Total Liabilities Trend (2016–2024)

This chart illustrates how Lipidor Ab's total liabilities have evolved over time, based on quarterly financial data. See Lipidor Ab (LIPI) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Lipidor Ab Competitors by Total Liabilities

The table below lists competitors of Lipidor Ab ranked by their total liabilities.

Company	Country	Total Liabilities
Ordinary Fully Paid Deferred Settlement AU:88EDA	Australia	AU$356.79K
Catenon S.A MC:COM	Spain	€2.60 Million
Aseana Properties Limited LSE:ASPL	UK	$79.70 Million
PERFORMANCE SHIPP. F:DS2	Germany	€236.42 Million
SUNEX S.A. WAR:SNX	Poland	zł205.21 Million
111 Inc NASDAQ:YI	USA	$1.99 Billion
RHYTHM Biosciences Ltd AU:RHY	Australia	AU$955.41K
Smithson Investment Trust PLC LSE:SSON	UK	GBX1.63 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Lipidor Ab's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Lipidor Ab worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.92	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.50	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.33	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Lipidor Ab's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Lipidor Ab (2016–2024)

The table below shows the annual total liabilities of Lipidor Ab from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	Skr3.86 Million ≈ $415.29K	-68.27%
2023-12-31	Skr12.16 Million ≈ $1.31 Million	-9.74%
2022-12-31	Skr13.47 Million ≈ $1.45 Million	+17.22%
2021-12-31	Skr11.49 Million ≈ $1.24 Million	+417.33%
2020-12-31	Skr2.22 Million ≈ $239.12K	+50.95%
2019-12-31	Skr1.47 Million ≈ $158.41K	-60.60%
2018-12-31	Skr3.74 Million ≈ $402.05K	+239.33%
2017-12-31	Skr1.10 Million ≈ $118.49K	-34.73%
2016-12-31	Skr1.69 Million ≈ $181.53K	--

About Lipidor Ab

ST:LIPI Sweden Drug Manufacturers - General

Market Cap

$18.82 Million

Skr174.88 Million SEK

Market Cap Rank

#25272 Global

#517 in Sweden

Share Price

Skr0.22

Change (1 day)

+0.00%

52-Week Range

Skr0.22 - Skr0.22

All Time High

Skr22.60